NDC 0187-0653

Duobrii

Halobetasol Propionate And Tazarotene

Duobrii is a Topical Lotion in the Human Prescription Drug category. It is labeled and distributed by Bausch Health Us, Llc. The primary component is Halobetasol Propionate; Tazarotene.

• Product ID: 0187-0653_28506879-692f-49d0-afb7-5febeb482df0
• NDC: 0187-0653
• Product Type: Human Prescription Drug
• Proprietary Name: Duobrii
• Generic Name: Halobetasol Propionate And Tazarotene
• Dosage Form: Lotion
• Route of Administration: TOPICAL
• Marketing Start Date: 2019-04-25
• Marketing Category: NDA / NDA
• Application Number: NDA209354
• Labeler Name: Bausch Health US, LLC
• Substance Name: HALOBETASOL PROPIONATE; TAZAROTENE
• Active Ingredient Strength: 0 mg/g; mg/g
• Pharm Classes: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Retinoid [EPC],Retinoids [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0187-0653-01

1 TUBE in 1 CARTON (0187-0653-01) > 100 g in 1 TUBE

• Marketing Start Date: 2019-04-25
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0187-0653-03 [00187065303]

Duobrii LOTION

• Marketing Category: NDA
• Application Number: NDA209354
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-04-25

NDC 0187-0653-01 [00187065301]

Duobrii LOTION

• Marketing Category: NDA
• Application Number: NDA209354
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: GM
• Marketing Start Date: 2019-04-25

Drug Details

Active Ingredients

Ingredient	Strength
HALOBETASOL PROPIONATE	.1 mg/g

Pharmacological Class

• Corticosteroid [EPC]
• Corticosteroid Hormone Receptor Agonists [MoA]
• Retinoid [EPC]
• Retinoids [CS]